Endometrial cancer begins when the cells of the inner lining of the uterus, known as the endometrium, become malignant. It is the most common type of cancer in the uterus and is divided into different types based on cell histology.
A retrospective study presented at the American Society of Clinical Oncology 2025 annual meeting evaluated women with endometrial neuroendocrine tumors and found that adjuvant treatment with...
Endometrial cancer risk can be influenced by genetic, hormonal, and metabolic factors, and understanding which can be crucial to prevention and early detection. Do you know the risk factors for endometrial...
Researchers found that the combination of benmelstobart, chemotherapy, and anlotinib yields improved response and progression-free survival in patients with advanced or recurrent endometrial cancer,...
Endometrial cancer risk can be influenced by genetic, hormonal, and metabolic factors, and understanding which can be crucial to prevention and early detection. Do you know the risk factors for endometrial...
Missed a key conference this year? We've got you covered! This curated slideshow brings together the most compelling moments, expert takeaways, and practice-changing data from the medical conferences you...
A recent clinical trial on adjuvant therapy for endometrial cancer investigated the impact of pembrolizumab on disease-free survival. But which patient population saw the most significant benefit? Test your...
In this video, Brian M. Slomovitz, MD, discusses his recent study demonstrating a significant improvement in disease-free survival with pembrolizumab in patients with dMMR endometrial cancer. He explains...
In this video, Anna Jo Smith, MD, MPH, MSc, discusses the use of two FDA-approved immunotherapy treatments for endometrial cancer in patients. She talks about health care disparities surrounding the...
Stephanie Blank, MD, answers questions about the session she hosted at The Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women's Cancer titled “The Future is Now: Determining the Fate of...
In this video, Kari E. Hacker, MD, PhD, discusses the results of her team's study examining the rate of HER2-expression among patients with endometrial cancer, as well as the eligibility of these patient...
In this video, Stephanie V. Blank, MD, and Warner K. Huh, MD, discuss the evolving role of the gynecologic oncologist, including the use of chemotherapy, benign surgery, and the management of patients with...